Invention Grant
- Patent Title: Targeted trans-splicing using CRISPR/Cas13
-
Application No.: US16994230Application Date: 2020-08-14
-
Publication No.: US11767528B2Publication Date: 2023-09-26
- Inventor: Jacob Borrajo
- Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
- Applicant Address: US MA Cambridge
- Assignee: Massachusetts Institute of Technology
- Current Assignee: Massachusetts Institute of Technology
- Current Assignee Address: US MA Cambridge
- Agency: Lathrop GPM LLP
- Agent Laura A. Labeots
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113 ; C12N9/22
Abstract:
This disclosure provides compositions and methods of using these compositions to mediate a targeted trans-splicing event on a pre-mRNA in a cell.
Public/Granted literature
- US20210071178A1 TARGETED TRANS-SPLICING USING CRISPR/CAS13 Public/Granted day:2021-03-11
Information query
